These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 14512089

  • 1. Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid disorders.
    Ozcan MA, Cömlekçi A, Demirkan F, Yüksel F, Sari I, Demir T, Ozsan GH, Orük G, Yeşil S, Undar B.
    Thromb Res; 2003 Jun 01; 110(4):243-7. PubMed ID: 14512089
    [Abstract] [Full Text] [Related]

  • 2. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar 01; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

  • 3. Increased plasma levels of free tissue factor pathway inhibitor in patients with Graves' disease.
    Morishita E, Hashimoto T, Asakura H, Saito M, Yamazaki M, Aoshima K, Yoshida T, Kato H, Matsuda T.
    Thromb Haemost; 1998 May 01; 79(5):919-23. PubMed ID: 9609221
    [Abstract] [Full Text] [Related]

  • 4. Thrombin activatable fibrinolysis inhibitor antigen levels are inversely correlated with plasminogen activator inhibitor-1 antigen levels in hyperthyroid patients.
    Akinci B, Comlekci A, Yener S, Demir T, Ozcan MA, Bayraktar F, Yesil S.
    Endocr J; 2007 Aug 01; 54(4):593-9. PubMed ID: 17690487
    [Abstract] [Full Text] [Related]

  • 5. Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism.
    Erem C, Kocak M, Nuhoglu I, Yilmaz M, Ucuncu O.
    Eur J Endocrinol; 2009 May 01; 160(5):863-8. PubMed ID: 19233920
    [Abstract] [Full Text] [Related]

  • 6. Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor and thrombomodulin levels in children with hypothyroidism.
    Alioğlu B, Kılıç N, Şimşek E, Dallar Y.
    J Clin Res Pediatr Endocrinol; 2012 Sep 01; 4(3):146-50. PubMed ID: 22985614
    [Abstract] [Full Text] [Related]

  • 7. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
    Saigo M, Abe S, Ogawa M, Yamashita T, Biro S, Minagoe S, Maruyama I, Tei C.
    Thromb Haemost; 2001 Nov 01; 86(5):1197-203. PubMed ID: 11816707
    [Abstract] [Full Text] [Related]

  • 8. Thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and activity assay in patients with primary hypothyroidism.
    Ermantas N, Guldiken S, Demir M, Tugrul A.
    Clin Appl Thromb Hemost; 2010 Oct 01; 16(5):568-73. PubMed ID: 19959491
    [Abstract] [Full Text] [Related]

  • 9. Elevated plasma levels of free-form of TFPI antigen in hypercholesterolemic patients.
    Morishita E, Asakura H, Saito M, Yamazaki M, Ontachi Y, Mizutani T, Kato M, Matsuda T, Nakao S.
    Atherosclerosis; 2001 Jan 01; 154(1):203-12. PubMed ID: 11137101
    [Abstract] [Full Text] [Related]

  • 10. Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism.
    Erem C, Ucuncu O, Yilmaz M, Kocak M, Nuhoglu İ, Ersoz HO.
    Endocrine; 2009 Dec 01; 36(3):473-8. PubMed ID: 19859836
    [Abstract] [Full Text] [Related]

  • 11. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism.
    Chadarevian R, Bruckert E, Leenhardt L, Giral P, Ankri A, Turpin G.
    J Clin Endocrinol Metab; 2001 Feb 01; 86(2):732-7. PubMed ID: 11158038
    [Abstract] [Full Text] [Related]

  • 12. Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism.
    Erem C, Ucuncu O, Yilmaz M, Kocak M, Nuhoglu I, Ersoz HO.
    Endocrine; 2009 Feb 01; 35(1):75-80. PubMed ID: 18958631
    [Abstract] [Full Text] [Related]

  • 13. Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension.
    Erdem Y, Usalan C, Haznedaroğlu IC, Altun B, Arici M, Yasavul U, Turgan C, Cağlar S.
    Am J Hypertens; 1999 Nov 01; 12(11 Pt 1):1071-6. PubMed ID: 10604482
    [Abstract] [Full Text] [Related]

  • 14. Blood coagulation and fibrinolysis in patients with hyperthyroidism.
    Erem C, Ersoz HO, Karti SS, Ukinç K, Hacihasanoglu A, Değer O, Telatar M.
    J Endocrinol Invest; 2002 Apr 01; 25(4):345-50. PubMed ID: 12030606
    [Abstract] [Full Text] [Related]

  • 15. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
    Lindgren A, Lindoff C, Norrving B, Astedt B, Johansson BB.
    Stroke; 1996 Jun 01; 27(6):1066-71. PubMed ID: 8650716
    [Abstract] [Full Text] [Related]

  • 16. Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts.
    Teng YC, Lin QD, Lin JH, Ding CW, Zuo Y.
    J Perinat Med; 2009 Jun 01; 37(4):343-8. PubMed ID: 19290852
    [Abstract] [Full Text] [Related]

  • 17. Physiological testosterone stimulates tissue plasminogen activator and tissue factor pathway inhibitor and inhibits plasminogen activator inhibitor type 1 release in endothelial cells.
    Jin H, Lin J, Fu L, Mei YF, Peng G, Tan X, Wang DM, Wang W, Li YG.
    Biochem Cell Biol; 2007 Apr 01; 85(2):246-51. PubMed ID: 17534406
    [Abstract] [Full Text] [Related]

  • 18. Serum levels of adhesion molecules ICAM-1 and VCAM-1 and tissue inhibitor of metalloproteinases, TIMP-1, are elevated in patients with autoimmune thyroid disorders: relevance to vascular inflammation.
    Jublanc C, Beaudeux JL, Aubart F, Raphael M, Chadarevian R, Chapman MJ, Bonnefont-Rousselot D, Bruckert E.
    Nutr Metab Cardiovasc Dis; 2011 Oct 01; 21(10):817-22. PubMed ID: 20685094
    [Abstract] [Full Text] [Related]

  • 19. The role of tissue factor in patients undergoing open repair of ruptured and nonruptured abdominal aortic aneurysms.
    Hobbs SD, Haggart P, Fegan C, Bradbury AW, Adam DJ.
    J Vasc Surg; 2007 Oct 01; 46(4):682-6. PubMed ID: 17764874
    [Abstract] [Full Text] [Related]

  • 20. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
    Petersen KR, Kjems LL, Skouby SO, Andersen LF, Jespersen J.
    Metabolism; 1996 Jul 01; 45(7):833-7. PubMed ID: 8692017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.